Skip to content

Clinical trials

Observational Diabetes Mellitus, Type 2 trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Phase: Observational Country / region: Netherlands Clear all

39 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20052
20062
20071
20082
20091
20102
20111
20125
20131
20142
20153
20172
20191
20203
20222
20233
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24
Unknown status6
Recruiting4
Terminated3
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S9
AstraZeneca4
Maastricht University Medical Center4
Radboud University Medical Center3
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)2
Amsterdam UMC, location VUmc2
Bayer2
Medical Research Foundation, The Netherlands2
Cambridge University Hospitals NHS Foundation Trust1
Henk Bilo, MD1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 239
Diabetes Mellitus10
Diabetes Mellitus, Type 17
Cardiovascular Diseases4
Obesity4
Hypertension3
Insulin Resistance3
Atherosclerosis2
Carcinoma, Hepatocellular2
Cognitive Dysfunction2

Trials

Showing 1 to 25 of 39. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.